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6 Summary 
Studies on the diagnosis, development and distribution of drug-resistant trypanosomes 
in cattle herds from selected sites of East and West Africa 
Tsetse transmitted bovine trypanosomosis or nagana is a major constraint to rural 
development in much of sub-Saharan Africa. In all these regions the main control method is 
to cure the disease in cattle through the administration of anti-trypanosomal molecules such as 
the diamidine diminazene aceturate and the phenanthridine derivative isometamidium 
chloride. These drugs are in use for more than 40 years. Due to the phenomenon of antigenic 
variation no vaccine has been developed until now. Furthermore, vector control even though 
technically feasible, is inherently confronted with problems of sustainability. Therefore, 
control of the disease will continue to depend largely on the use of trypanocidal drugs for the 
foreseeable future. However, there have been several reports in recent times indicating an 
increase of the drug resistance incidence in trypanosomes. The number of case reports on 
drug resistance is growing, yet there is lack of reliable data at regional level on its true 
prevalence. 
The present study aimed to assess the development and distribution of drug-resistant 
trypanosomes in cattle herds from selected sites of East Africa (Metekel, north-west Ethiopia; 
Upper Didessa Valley, west Ethiopia; Mukono County, south-east Uganda) and West Africa 
(province of Kénédougou, south-west Burkina Faso). Longitudinal field studies were 
conducted to estimate the incidence of trypanocidal drug resistance in high risk areas. Several 
in vivo and in vitro tests were used to characterize the drug sensitivity of trypanosome field 
stocks. The polymerase chain reaction (PCR) was evaluated and its diagnostic potential to 
monitor the efficacy of prophylactic and curative treatments tested.  
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Block treatment of cattle with isometamidium in high trypanosomosis risk villages in 
Metekel, Upper Didessa Valley and Kénédougou indicated that isometamidum resistance in 
Trypanosoma congolense was widespread but varied in its incidence between villages, 
indicating a relation with trypanosomosis risk and, possibly, other factors. Field-derived 
indicators of isometamidium resistance were supported by in vivo and in vitro demonstration 
of resistance to both isometamidium and diminazene. Clones originating from cattle primary 
isolates of T. congolense from Metekel and Kénédougou and tested in mice expressed a high 
level of resistance to both isometamidium and diminazene. It was concluded that 
chemotherapeutic agents per se would not provide a viable option for the control of 
trypanosomosis at Metekel and Kénédougou on a long-term basis if such resistance at clonal 
level was highly prevalent. In contrast, there appeared to be no resistance of trypanosomes to 
the common used drugs in cattle of Mukono. All the same, given the apparent development of 
resistance to trypanocidal drugs that has occurred in other tsetse-infested areas, anti-
trypanosomal compounds should be judiciously applied in Mukono County as well. PCR 
proved to be a highly sensitive and specific tool to monitor the therapeutic and prophylactic 
efficacy and disease progression in bovine trypanosomosis. Depending on the availability of 
financial support, PCR could provide an ideal tool to assess trypansomosis risk in endemic 
areas and to monitor the success of tsetse and trypanosomosis control programmes. 
Since there is no indication that new trypanocidal drugs will become available in the near 
future, it is of greatest importance that measures be taken to avoid or delay the development 
of resistance and to maintain the efficacy of the currently available drugs. The most efficient 
way is the reduction in the number of treatments in order to reduce the selection pressure 
caused by these drugs. Mass treatments at short intervals should be avoided, particularly in 
areas of high challenge. Drug use should be reduced through vector control and by decreasing 
host-vector contact. If resistance to both isometamidium and dimiazene is present at the level 
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of individual trypanosomes, trypanocidal drug use should be terminated, except for the 
treatment of clinical cases. Vector control activities should be maximised and cross-breeding 
with trypanotolerant cattle should be encouraged. 
